The Pennant Group, Inc. (NASDAQ:PNTG - Get Free Report) has received an average recommendation of "Moderate Buy" from the eight research firms that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a hold rating and seven have given a buy rating to the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $41.60.
A number of brokerages have recently commented on PNTG. Wells Fargo & Company increased their target price on shares of The Pennant Group from $45.00 to $46.00 and gave the company an "overweight" rating in a research report on Tuesday, August 11th. Royal Bank Of Canada boosted their price target on shares of The Pennant Group from $42.00 to $44.00 and gave the stock an "outperform" rating in a research report on Thursday, August 20th. Weiss Ratings raised shares of The Pennant Group from a "buy (b-)" rating to a "buy (b)" rating in a research note on Wednesday, August 19th. Wall Street Zen upgraded shares of The Pennant Group from a "hold" rating to a "buy" rating in a report on Saturday, June 20th. Finally, Truist Financial raised their target price on shares of The Pennant Group from $42.00 to $48.00 and gave the stock a "buy" rating in a research note on Tuesday, July 14th.
Get Our Latest Report on PNTG
The Pennant Group Stock Performance
Shares of NASDAQ:PNTG opened at $39.20 on Friday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.20 and a quick ratio of 1.20. The Pennant Group has a 1 year low of $22.25 and a 1 year high of $42.69. The firm has a market capitalization of $1.37 billion, a PE ratio of 43.56, a P/E/G ratio of 2.56 and a beta of 1.27. The business's 50 day moving average price is $39.46 and its 200-day moving average price is $35.13.
The Pennant Group (NASDAQ:PNTG - Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $0.36 earnings per share for the quarter, beating analysts' consensus estimates of $0.33 by $0.03. The Pennant Group had a return on equity of 10.33% and a net margin of 2.93%.The company had revenue of $297.98 million for the quarter, compared to analyst estimates of $288.71 million. The Pennant Group has set its FY 2026 guidance at 1.340-1.410 EPS. As a group, equities research analysts expect that The Pennant Group will post 1.18 earnings per share for the current fiscal year.
Institutional Investors Weigh In On The Pennant Group
Several hedge funds and other institutional investors have recently made changes to their positions in the stock. GAMMA Investing LLC increased its stake in The Pennant Group by 34.6% during the 2nd quarter. GAMMA Investing LLC now owns 1,568 shares of the company's stock worth $58,000 after buying an additional 403 shares during the period. Caitong International Asset Management Co. Ltd boosted its position in The Pennant Group by 154.2% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 1,182 shares of the company's stock valued at $33,000 after buying an additional 717 shares during the period. Nykredit A S acquired a new position in shares of The Pennant Group in the second quarter worth $29,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of The Pennant Group by 4.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,394 shares of the company's stock worth $488,000 after acquiring an additional 857 shares in the last quarter. Finally, Parallel Advisors LLC increased its position in shares of The Pennant Group by 1,186.8% during the first quarter. Parallel Advisors LLC now owns 1,364 shares of the company's stock worth $42,000 after acquiring an additional 1,258 shares during the period. Institutional investors and hedge funds own 85.88% of the company's stock.
About The Pennant Group
(
Get Free Report)
The Pennant Group, Inc is a healthcare services company that operates home health, hospice and personal care businesses, as well as senior living communities. Its services are designed to support older adults and other patients in their homes, residential settings and communities, with offerings that may include skilled nursing, therapy, hospice care, assisted living and memory care.
The company serves patients and residents through a network of affiliated operating companies and communities across multiple U.S.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider The Pennant Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Pennant Group wasn't on the list.
While The Pennant Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.